CollPlant Biotechnologies Ltd Ordinary Shares (CLGN)
Stock · NASDAQ · Health Care
$3.63as of 10/16/2026
Price chart
Active signals
CLGN Signal Track Record
How signals performed across all stocks →What CLGN's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 35 | 0.0% | 49% | August 24, 2026 |
| Bollinger Band Breakdown | 21 | -0.7% | 48% | June 5, 2026 |
| Bollinger Band Breakout | 19 | -17.5% | 21% | August 31, 2026 |
| 200-Day Moving Average TouchActive now | 11 | -10.7% | 27% | September 30, 2025 |
| Any 20-session window (baseline) | -5.6% | 36% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About CLGN
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology. The company offers regenerative dermal and soft tissue filler…
- Sector
- Health Care
- Industry
- Industrial Specialties
- Employees
- 39
- Website
- www.collplant.com
Fundamentals
- 1-day range
- $3.5$4.44
- Market cap
- $6.25M
- P/E (trailing)
- —
- P/E (forward)
- -10.31
- EPS (trailing)
- $-7.78
- Dividend yield
- —
- Beta
- 0.62
- Avg. volume
- 352.8K
- Dividend pay date
- November 21, 2016
CollPlant Biotechnologies Ltd Ordinary Shares Competitors
Chosen by industry and closest market cap.
- CLGNCollPlant Biotechnologies Ltd Ordinary Shares$3.63▼ 1.49%Market cap $6.25MP/E —$2.64$26.8
- HSCSHeartSciences Inc. Common Stock$3.02▼ 5.03%Market cap $7.80MP/E —$1.63$5.25
- FEEDENvue Medical Inc. Common Stock$0.371▼ 24.29%Market cap $3.67MP/E —$0.2001$79.43
- CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares$1.9▼ 2.56%Market cap $8.98MP/E —$1.45$14.8
- FGIFGI Industries Ltd. Ordinary Shares$7.49▼ 0.27%Market cap $9.13MP/E —$3.14$19.93
- COCHWEnvoy Medical Inc Warrant$0.0362▲ 10.03%Market cap $2.61MP/E —$0.02$0.095
- BBLGBone Biologics Corp Common Stock$0.395▲ 1.80%Market cap $1.66MP/E —$0.3787$2.76
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| CLGN CollPlant Biotechnologies Ltd Ordinary Shares | $6.25M | — | $3.63 | ▼ 1.49% | $2.64$26.8 |
| HSCS HeartSciences Inc. Common Stock | $7.80M | — | $3.02 | ▼ 5.03% | $1.63$5.25 |
| FEED ENvue Medical Inc. Common Stock | $3.67M | — | $0.371 | ▼ 24.29% | $0.2001$79.43 |
| CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | $8.98M | — | $1.9 | ▼ 2.56% | $1.45$14.8 |
| FGI FGI Industries Ltd. Ordinary Shares | $9.13M | — | $7.49 | ▼ 0.27% | $3.14$19.93 |
| COCHW Envoy Medical Inc Warrant | $2.61M | — | $0.0362 | ▲ 10.03% | $0.02$0.095 |
| BBLG Bone Biologics Corp Common Stock | $1.66M | — | $0.395 | ▲ 1.80% | $0.3787$2.76 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC WorkloadsYahoo · 9/24/2026
- CollPlant Announces Publication Of Joint Research Conducted By Its Subsidiary LightSolver Showing Photonic Computing Advantage Over GPUsBenzinga · 9/24/2026
- CollPlant Regains Compliance with Nasdaq Minimum Bid Price RequirementYahoo · 9/22/2026
- CollPlant Biotechnologies Regains Nasdaq ComplianceBenzinga · 9/22/2026
- CollPlant Biotechnologies Ltd. (CLGN) Discusses Acquisition of Lightsolver and Strategic Entry Into High-Performance Photonic Computing - SlideshowSeekingAlpha · 9/18/2026
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga · 9/17/2026
- CollPlant Biotechnologies Ltd. (CLGN) Discusses Acquisition of Lightsolver and Strategic Entry Into High-Performance Photonic Computing TranscriptSeekingAlpha · 9/17/2026
Insider Activity
Insider Actions →- Abelis Bar Berta · September 3, 2026 · Grant201.1K
- Rotem Eran · September 3, 2026 · Grant510.4K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
CollPlant Q2 Earnings Miss Estimates Significantly
CollPlant Biotechnologies reported second-quarter results that fell short of analyst expectations. The company posted an adjusted loss of $1.69 per share, missing the estimate of $0.24, while sales of $108,000 were well below the projected $1.466 million. This significant gap between actual performance and market forecasts highlights current operational challenges for the firm.
CollPlant Q2 Earnings Miss Estimates Significantly. CollPlant Biotechnologies reported second-quarter results that fell short of analyst expectations. The company posted an adjusted loss of $1.69 per share, missing the estimate of $0.24, while sales of $108,000 were well below the projected $1.466 million. This significant gap between actual performance and market forecasts highlights current operational challenges for the firm.